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Abstract
Objectives The biocompatible 2-methacryloyloxyethyl phosphorylcholine (MPC)-polymers, which mimic a biomembrane, re-
duce protein adsorption and bacterial adhesion and inhibit cell attachment. The aim of this study is to clarify whether MPC-
polymer can suppress the bacterial adherence in oral cavity by a crossover design. We also investigated the number of
Fusobacterium nucleatum, which is the key bacterium forming dental plaque, in clinical samples.
Materials and methods This study was a randomized, placebo-controlled, single-blind, crossover study, with two treatment
periods separated by a 2-week washout period. We conducted clinical trial with 20 healthy subjects to evaluate the effect of 5%
MPC-polymer mouthwash after 5 h on oral microflora. PBS was used as a control. The bacterial number in the gargling sample
before and after intervention was counted by an electronic bacterial counter and a culture method. DNA amounts of total bacteria
and F. nucleatum were examined by q-PCR.
Results The numbers of total bacteria and oral streptcocci after 5 h of 5% MPC-polymer treatment significantly decreased,
compared to the control group. Moreover, the DNA amounts of total bacteria and F. nucleatum significantly decreased by 5%
MPC-polymer mouthwash.
Conclusions We suggest that MPC-polymer coating in the oral cavity may suppress the oral bacterial adherence.
Clinical relevance MPC-polymer can be a potent compound for the control of oral microflora to prevent oral infection.
Keywords 2-Methacryloyloxyethylphosphorylcholine .Clinical study .Oral infection .Oralbacteria .Fusobacteriumnucleatum
Introduction
Dental caries, periodontal disease, and oral mucosal lesions
are major public health problems worldwide, which are
caused by oral biofilm. Systemic diseases, such as cardiovas-
cular disease and complications during pregnancy, have been
reported to relate with oral microflora [1, 2]. In particular,
aspiration pneumonia has been caused by oral bacteria for
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elderly people and immunocompromised patients [3, 4]. Oral
health is closely related with general health and quality of life
(QOL) [5]. These facts indicate that it is important to suppress
dental plaque formation and development to maintain QOL.
In the process of dental plaque formation, acquired enamel
pellicle forms on hard tissue such as tooth surface [6], and then,
early colonizers were primarily composed of Gram-positive spe-
cies such as Streptococcus adhere to the surfaces. Secondary
colonizers attach primary bacteria already anchored to teeth or
tissues, which is important for the development of dental plaque
[7, 8]. Fusobacteria play a central role in physical bridges to
mediate the co-aggregation of bacterial cells and promote the
anaerobic microenvironment [9]. Fusobacterium nucleatum is
the predominant species in the healthy oral cavity and markedly
increases in the oral cavity with periodontal disease. The inhibi-
tion of biofilm formation by periodontopathic bacteria including
F. nucleatum, therefore, is regarded as an effective strategy for
preventing periodontal diseases.
It has been shown that the biological properties of a coating of
biocompatible 2-methacryloyloxyethyl phosphorylcholine
(MPC)-polymers, which have a phospholipid polar group that
mimics a biomembrane, are completely harmless to humans,
reducing protein adsorption and bacterial adhesion and inhibiting
cell attachment [10–12].We previously reported that a coating of
non-aqueous MPC-polymer on coverslips decreased bacterial
adhesion, suppressed biofilm formation, and attributed these ef-
fects to the Bsuperhydrophilicity^ of MPC-polymer-coated sur-
faces [13]. MPC-polymer application markedly inhibited both
the adherence and biofilm formation of Streptococcus mutans
on saliva-coated hydroxyapatite and streptococcal adherence to
oral epithelial cells and reduced the adherence of F. nucleatum to
streptococcal biofilms in vitro [14]. In the small-scale clinical
trial, mouth rinsing with MPC-polymer inhibited the increase
of oral bacterial numbers, especially S. mutans in vivo, indicating
that MPC-polymer coating in oral cavity can be useful for
preventing oral infections including dental caries by preventing
microbial adherence to oral surfaces [14]. Clinical effect ofMPC-
polymer on preventing microbial adherence to oral surfaces
needs to verify more details because the previous study was a
small-scale trial and parallel study design. The aimof this study is
to clarify whether MPC-polymer can suppress bacterial adher-
ence in oral cavity by a crossover clinical trial. We also investi-
gated the number of F. nucleatum, which is the key bacterium
forming dental plaque, using clinical samples.
Materials and methods
Study design
The study was a randomized, placebo-controlled, single-blind,
crossover study, with two treatment periods separated by a 2-
week washout period carried out at Tokushima University
between March and July 2016. The flow of two treatments
was phosphate buffered saline (PBS, 0.01 M, pH 7.4) as a
control followed by 5% MPC-polymer dissolved with steril-
ized water, or 5% MPC-polymer followed by PBS (Fig. 1a).
This clinical trial was approved by the Ethics Committee of
Tokushima University Hospital (approval no. 2416).
Subjects
The sample size calculation was performed on the basis of our
previous results [14]. Based on a standard deviation of 0.9 (the
fold increase of bacterial number after intervention), a signif-
icant level of α = 0.05, and a statistical power of 0.9, we
calculated that 18 subjects would be necessary to detect a
statistically significant and clinically relevant difference of
δ = 0.9. The subjects were recruited at Tokushima
University. We conducted clinical trial with 20 healthy sub-
jects to evaluate the effect of MPC-polymer mouthwash on
oral microflora. Subjects who are wearing orthodontic appli-
ances and removable partial dentures, had any antibiotic ther-
apy in the past 3 months, are pregnant, and are breast-feeding
women were excluded. All subjects received the two treat-
ments and were analyzed (Fig. 1b).
Examination of oral health status
Clinical oral examinations were carried out before this clinical
intervention. As a caries experience, we used DMF rate.
Periodontal index (PI) [15], oral hygiene index (OHI) [16],
and tongue coating status evaluation were also used. In the
tongue coating status evaluation, the total area was recorded
with a score from 0 to 4, where a score of 0 represented no
tongue coating; 1, a thin coating of less than one third of the
back of the tongue; 2, a thin coating of less than two thirds of
the tongue or less than one-third covered with a thick coating;
3, a thin coating of more than two thirds of the tongue, or less
than two thirds covered with a thick coating; and 4, more than
two thirds of the tongue covered with a thick coating [17].
Evaluation of all examination indexes were performed by
two calibrated and trained examiners (NF and HN).
Clinical intervention
After the subjects brushed their teeth as usual, we harvested an
oral bacterial sample by having them gargle with 5 mL of PBS
for 20 s in a similar method that was previously reported [18].
Subjects then were treated with 5 mL of 5%MPC-polymer or
PBS (control) for 20 s. At 5 h after treatment with 5% MPC-
polymer, an oral bacterial sample was taken again by having
them gargle with 5 mL of PBS for 20 s. The subjects were
prohibited from eating during the 5-h period. Outcome mea-
sures were the number and DNA amounts of oral bacteria
before and after intervention by using electronic bacterial
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counter, culture method, and quantitative real-time polymer-
ase chain reaction (q-PCR) (Fig. 2).
Counting the number of oral bacteria
The number of total bacteria in the gargling sample before and
after intervention was counted by rapid oral bacteria counting
system (Panasonic Healthcare Co. Ltd., Osaka, Japan) apply-
ing the dielectrophoresis and impedance measurement theory
[19]. Fifty microliters of the sample was added in the cup
containing its exclusive solution, and the number of total bac-
teria was automatically counted. The cell numbers in the gar-
gling sample were determined before and after intervention.
As the lowest detection limit of this machine is 1 × 105 cells/
ml, actual bacterial counts less than this limit were displayed
as 1 × 105 cells/ml [20].
The number of bacteria was also counted by a culturemeth-
od using a spiral plater (model D; Spiral Systems Inc.,
Cincinnati, OH, USA), which is a device that accurately dis-
tributes a liquid sample onto a rotating agar plate for precise
bacterial enumeration. Collected samples were diluted 10-fold
with saline and 50 μl of diluted samples was inoculated onto
agar plates automatically. A blood agar plate (Kyokuto,
Tokyo, Japan) supplemented with 5% sheep blood, mitis-
salivarius agar plate (Becton Dickinson, Sparks, MD, USA),
and mitis-salivarius agar containing 15% sucrose and 3.3 mg/l
Washout periods
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PBS 
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A
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Analysis
Assessed for eligibility (n=20)
Excluded (n=0) 
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Other reasons (n=0) 
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(n=0)
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Fig. 1 a The flow of two
treatment and washout period.
The study was a randomized,
placebo-controlled, single-blind,
crossover study, with two
treatment periods separated by a
2-week washout period. b Flow
diagram of this study design
phases including enrollment and
allocation criteria
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bacitracin as described previously [21] for total anaerobic bac-
teria, oral streptococci, and S. mutans, respectively, were used.
The plates were incubated at 37 °C for 2 days anaerobically
using the Anaeropack system (Mitsubishi Gas Chemical,
Tokyo, Japan), and the resulting colonies, i.e. CFU, were
counted. The numbers of CFU were determined before and
after intervention.
Microbial enumeration by q-PCR
The collected gargled samples were used for q-PCR with the
specific primer pairs based on 16S ribosomal RNA. Samples
were first centrifuged for 10 min, and their bacterial genomic
DNA was extracted and purified using Maxwell® Rapid
Sample Concentrator (RSC) DNA FFPE Kit-PKK Custom
(Promega Corporation, Wisconsin, USA) and Maxwell®
RSC Instrument (Promega Corporation) according to the man-
ufacturer’s instructions. In this study, we did not exclude DNA
from dead cells and extracellular DNA before DNA isolation
procedure. Real-time PCR was performed with the Fast
SYBR® Green Master Mix (Applied Biosystems, Foster City,
CA, USA) using the StepOnePlus Real Time PCR System
(Applied Biosystems). The following specific primers were
used to amplify fragments of Universal: 5 ′-TCCT
ACGGGAGGCAGCAGT-3 ′ (sense) and 5 ′-GGAC
TACCAGGGTATCTAATCCTGTT-3′ (antisense) [22], and
16S rRNA of F. nucleatum: 5′-CGCAGAAGGTGAAA
GTCCTGTAT-3′ (sense) and 5′- TGGTCCTCACTGAT
TCACACAGA-3′ (antisense) [23]. A purified PCR product
amplified from F. nucleatum was used for generating a quanti-
tative standard curve. Amplification conditions of the q-PCR
were 95 °C for 10 min for initial denaturation, 40 denaturation
cycles at 95 °C for 3 s and annealing/extension at 60 °C for 30 s.
For the relative quantification, the copy numbers of both bac-
terial genes were normalized to the copy number of the 16S
rRNA gene using threshold cycle (ΔΔCt) method. Threshold
cycle values and data analyses were performed by StepOne™
Software v2.2 (Applied Biosystems). The bacterial copy num-
bers of 5 h after treatment with 5% MPC-polymer were com-
pared to that of 5 h after treatment with PBS (control).
Statistical analysis
All statistical analyses were evaluated by Student’s t test
which is a common parametric test for comparing two groups
with normal distributions. q-PCR was conducted in triplicate
and statistical analyses were performed. All analyses were
performed using SPSS, version 24.0 (SPSS Japan Inc.,
Tokyo, Japan). Differences were considered significant when
probability values were less than 5%.
Results
Oral health status of subjects
We investigated the clinical oral status using DMF rate, PI,
OHI, and tongue coating status against 20 subjects before the
intervention (Table 1). The mean age of 20 subjects was 30 ±
9.25, and sex distribution of the subjects was 8 males and 12
females. Average rate of DMF index in the subjects was 21.4 ±
15.7%. Averages of PI and OHI were 0.45 ± 0.6 and 0.98 ± 1.1,
respectively. Average of tongue coating status was 1.53 ± 0.6.
Self 
brushing
Treatment with 
MPC-polymer  
or PBS
Evaluate the number of  
oral bacteria using  
Electronic bacterial counter 
Culture method 
q-PCR
5 hours
Gargling 
with PBS
Gargling 
with PBS
Evaluate the number of  
oral bacteria using  
Electronic bacterial counter 
Culture method 
q-PCR
Fig. 2 Application regimen of one intervention by using a control or 5%
MPC-polymer and items of evaluation using the samples. After the sub-
jects brushed their teeth as usual, we harvested an oral bacterial sample by
having them gargle with 5 ml of phosphate buffered saline (PBS) for 20 s.
Subjects then are treated with 5 ml of 5% MPC-polymer or PBS (as a
control) for 20 s. After 5 h of intervention, an oral bacterial sample was
taken again. The subjects were prohibited from eating during the 5-h
period. Collected gargling samples were enumerated for the number of
bacteria using electronic bacterial counter, a culture method and quanti-
tative real-time polymerase chain reaction (q-PCR)
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Effects of mouthwash with 5% MPC-polymer
on the number of oral bacteria
We investigated the effect of mouthwash with MPC-polymer on
bacterial colonization in the oral cavity of the subjects. The total
bacterial numbers after 5 h in MPC-polymer-treated group were
significantly lower than that of control group (P < 0.05) by auto-
matic counting using a rapid oral bacteria quantification system
(Fig. 3a). Data obtained by culture method also showed that the
numbers of CFU after 5 h of total bacteria and oral streptococci in
MPC-polymer-treated group were significantly lower than that of
control group (P < 0.05 and P < 0.01, respectively) (Fig. 3b, c). In
addition, The CFU counts of S. mutans in MPC-polymer-treated
group were also lower than that of control group, but there was no
statistical significance (Fig. 3d). We also confirmed that the num-
bers of cells and CFU in control and 5% MPC-polymer-treated
group before intervention showed no significant difference.
The copy numbers of the 16S rRNAgene of total bacteria and
F. nucleatum were evaluated by q-PCR. The copy numbers of
total bacteria andF. nucleatum in control and 5%MPC-polymer-
treated group showed no significant difference before interven-
tion. The copy numbers of total bacteria and F. nucleatum after
5 h in 5% MPC-polymer-treated group were significantly lower
than those in control group (P < 0.05) (Fig. 4).
Table 1 Baseline characteristics
and clinical oral health status of
the subjects
Total subjects (n = 20) MPC-PBS group (n = 10) PBS-MPC group (n = 10)
Age (years) 30.0 (± 9.3) 30.9 (± 10.1) 29.1 (± 8.8)
Female/male 12/8 5/5 7/3
DMF rate (%) 21.4 (± 15.7) 16.5 (± 18.0) 25.8 (± 12.9)
Periodontal index (PI) 0.45 (± 0.6) 0.5 (± 0.6) 0.2 (± 0.3)
Oral hygiene index (OHI) 0.98 (± 1.1) 1.1 (± 1.0) 0.5 (± 1.0)
Tongue coating test 1.53 (± 0.6) 1.6 (± 0.5) 1.4 (± 0.7)
Average (standard deviation)
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Fig. 3 The effect of mouthwash
with 5% MPC-polymer coating
on oral bacterial numbers. The
bacterial numbers in the gargled
sample were counted by an
electronic bacterial counter and a
culture method. In the culture
method, gargling samples were
spread on agar plates
supplemented with 5% sheep
blood, mitis-salivarius (MS) agar
plate and MS agar containing
15% sucrose and 3.3 mg/l
bacitracin (MSB) plate, using a
spiral plater device. Colony-
forming units (CFUs) were
counted after anaerobic incuba-
tion at 37 °C for 2 days.
The data using a an electronic
bacterial counter and b agar plates
supplemented with 5% sheep
blood, c MS agar plates and d
MSB plates in culture procedure
were shown. The numbers of cells
and CFU in control and 5%MPC-
polymer-treated group before
intervention showed no
significant difference. Data
represent the mean ± S.D. *P <
0.05 and **P < 0.01
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Discussion
It is well known that microorganisms often survive within
biofilms, which results in environmental problems and various
infectious diseases [24]. During the biofilm formation and its
maturation, co-aggregation and co-adhesion of bacteria are criti-
cal [9]. Inhibition of bacterial adherence, therefore, has been
considered an effective strategy for prevention of infectious dis-
eases. To destroy the biofilm in the oral cavity, many studies have
been conducted on the effective strategies in dental hygiene prac-
tice. As a mechanical method, tooth brushing and tongue scrap-
ing are used to remove microorganisms. Mouthrinses and tooth-
pastes containing antibacterial compounds, such as chlorhexi-
dine, cetylpyridinium chloride (CPC), and triclosan, are com-
monly used to prevent the growth and the biofilm formation of
bacteria. Currently used disinfectants, however, induce adverse
effects, such as extrinsic brown staining of teeth and restorations,
toxic to mucous membranes, burning sensation, and mouth irri-
tation [25]. Taking into account these disadvantages of the disin-
fectants, a novel strategy to inhibit the bacterial adherence and
dental plaque formation is required.
Here, we demonstrated the inhibitory effects of mouthwash
with 5%MPC-polymer coating in the oral cavity on the number
of oral bacteria by a randomized, crossover clinical study.
Importantly, MPC-polymer has been approved by the Food
and Drug Administration (FDA) and applied for various pur-
poses, such as contact lenses and cosmetics. We previously have
shown that (i) MPC-polymer coating to plastic coverslips re-
duces retention of human pathogenic microorganisms including
Staphylococcus aureus, S. mutans, Pseudomonas aeruginosa,
andCandida albicans in vitro [13], and (ii) MPC-polymer appli-
cation markedly inhibited both the adherence and biofilm forma-
tion of S. mutans on saliva-coated hydroxyapatite and oral epi-
thelial cells [14]. These findings show that superhydrophilicity of
MPC-polymer-coated surfaces, but not disinfectant action, may
inhibit the adherence of pathogenic bacteria to teeth and/or oral
mucosa. In addition, MPC-polymer coating has a role for reduc-
ing the protein adsorption. However, the salivary proteins includ-
ed in the acquired enamel pellicle, such as histatin and statherin,
have protective effects of demineralization, prevention of acidic
dissolution of the teeth, and antibacterial/antifungal effects
[26–28]. In the future, therefore, the development of MPC-
polymer with the ability of absorbance of selective salivary pro-
teins are desired.
Fusobacteria play a central role as physical bridges to medi-
ate the co-aggregation of bacterial cells and promote an anaer-
obic microenvironment. F. nucleatum is a predominant and key
bacterium in the dental plaque formation and closely associates
with other periodontal pathogens [9]. Production of hydrogen
sulfide by F. nucleatum is known to be associated with halitosis
[29]. MPC-polymer coating inhibits the adherence of F.
nucleatum to streptococcal biofilms in vitro [14]. Here, we
showed that 5% MPC-polymer gargle significantly suppressed
the increase of F. nucleatum to 50% (Fig. 4b). These findings
suggest that mouthwash with MPC-polymer coating may sup-
press the adherence of F. nucleatum to the oral cavity and may
inhibit the maturation of dental plaque. F. nucleatum has been
reported to be involved in the development of colon cancer via
activation of oncogenic signaling, recruitment of tumor-
infiltrating immune cells, and interference of the host immunity
[30–32]. The control of F. nucleatum is important to reduce the
risk of colon cancer as well as oral infectious diseases.
To count the bacterial number in the oral cavity, we
employed the gargling method. Although it is almost impossi-
ble to count the actual bacterial number in the oral cavity, we
can estimate the actual number from a sample that is appropri-
ately taken. It has been reported that the bacterial number ob-
tained by the gargling method well reflects the number of
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bacteria that inhabit in the oral cavity [18]. The bacteria adhered
to oral mucosa, tooth surfaces, and tongue, therefore, can be
collected by the gargling and the bacterial number in the gar-
gling sample may be well correlated to the whole number of
bacteria inhabiting in the oral cavity. To assess the number of
oral bacteria in gargling sample, we used a device adopted for
rapid oral bacteria quantification system (electronic bacterial
counter). Although the electronic bacterial counter has a limit
of the detection of bacterial counts (less than 105 cells/ml), the
number of microorganisms in the saliva usually exceeds 105
cells/ml [20]. The result by an electronic counting method did
not show a highly significant difference in comparison with the
result by a culture method (Fig. 3a, b). A difference in bacterial
viability may be one of the reasons for which there was low
significant difference. Moreover, an electronic bacterial counter
is lower sensitivity than the culture method. However, the data
evaluated by electronic bacterial counter was well correlated
with the data evaluated by a culture method (r2 = 0.7814). As
the electronic bacterial counter is simple and easy-to-use oper-
ation, this device is useful for counting oral bacteria. Therefore,
we can easily check the number of oral bacteria in gargling
sample from elderly people at home and compromised hosts
in a hospital. We will examine the effect of MPC-polymer
coating for elderly people and compromised hosts in the future.
In conclusion, we suggest thatMPC-polymer coating in the
oral cavity may suppress the oral bacterial adhesion. We be-
lieve that MPC-polymer is a potent compound for the control
of oral microflora to prevent oral infection including dental
caries, periodontal diseases, and halitosis. In this study, we
focused on the oral bacterial adherence after MPC-polymer
treatment. To know the initial microorganism recovery after
the intervention, we will evaluate the clinical oral health status
including the status of tongue coating.
As MPC-polymer treatment protected human oral
keratinocytes from the damage induced by CPC [33], MPC-
polymer can be used for the purpose on the protection from
the damage of oral mucosa in combination with other com-
mercially available disinfectants.
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